🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The principal objective is to determine the impact of phenelzine on the act...
Status
Completed
Location
CHU Bicêtre
Start Date
2020-11-20
Trial ID
NCT04590222
Treatments Being Tested
Background: Parkinsons disease (PD) causes slow movement, stiffness, and p...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2017-09-25
Trial ID
NCT03104725
Treatments Being Tested
The purpose of this study is to determine if CX157 is effective and safe in...
Status
Completed
Location
Synergy Escondido
Start Date
2010-11
Trial ID
NCT01246908
Treatments Being Tested
Study TRD subjects' resistance to at least 2 different antidepressants, we ...
Status
Completed
Location
Cleveland Clinic
Start Date
2016-07
Trial ID
NCT03109717
Treatments Being Tested
The objectives of this study were to examine the cardiovascular sensitivity...
Status
Completed
Location
Comprehensive Phase One
Start Date
2010-09
Trial ID
NCT01633437
This pilot study will evaluate the efficacy of the monoamine oxidase inhibi...
Status
Terminated
Location
New York State Psychiatric Institute
Start Date
2007-03
Trial ID
NCT00535262
Treatments Being Tested
The primary objective of this study is to determine the efficacy of both lo...
Status
Completed
Location
Massachusetts General Hospital, Harvard Medical School (HU)
Start Date
2011-11
Trial ID
NCT01418209
Treatments Being Tested
There are already recently published data on the tolerability and efficacy ...
Status
Completed
Location
Service de physiologie - Explorations fonctionnelles - CHU de Strasbourg - France
Start Date
2022-04-11
Trial ID
NCT05530668
Dysthymic disorder (DD) denotes chronic depression with fewer symptoms than...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2006-01
Trial ID
NCT01852383
Treatments Being Tested